Sir,
We read the article [1] in May 2017 edition of your reputed journal. We have been employing the "scleral tuck technique" described by the authors in the past to fixate intraocular lens (IOL) to sclera in the absence of capsular support. However, we encountered that, out of six eyes where we employed this technique, in one eye, haptic on one side got dislodged within few days of the surgery, which we had to refixate using glue. We presumed that, in the absence of glue (which is used in "scleral flap technique" and not in "scleral tuck technique"), simply tucking the haptic may not be adequately secure in early postoperative period.
The first publication of "scleral tuck technique" is of Scharioth et al. in 2010 of 63 eyes with 7-month follow-up as mentioned in the article. However, one can appreciate that there has not been any publication reporting either large number of patients or very long-term results after that. The fact that scleral tuck technique was more or less replaced by scleral flap technique with glue leads to the presumption that it was not found secure by surgeons and needed further modifications. However, the exact reason for this shift is not apparent from the literature. Now, there is renewed interest in scleral tuck technique and authors share a modification to make it more secure. To make "scleral tuck technique" more secure, we have modified the step of tucking of haptic. Instead of just making a tunnel in single plane and tucking the haptic, we do it in four steps as depicted in Fig. 1 . In step 1, a scleral groove of half thickness is made just in front of the scleral port from which the haptic has been exteriorized. Then, a bent 30-gauge needle is passed from the base of the groove and it comes out on the surface after traversing about 1 mm of the sclera. In step 2, the haptic is tucked in this groove and comes out on the surface again. In step 3, a new groove is made in front of this exteriorized haptic and it remains intrasclerally. Finally, in step 4, the haptic is tucked in this groove. Thus, instead of a groove in single plane haptic comes out of sclera, it goes in, and then comes out again before finally getting buried intrasclerally. This locks the haptic by the forces of scleral tissue acting on haptic in opposing directions by virtue of intraocular pressure. Thus, ensuring watertight closure with slightly higher intraocular pressure before ending the surgery is also an integral part of this technique. This is not possible in glued IOL technique as the site has to be kept dry for glue to act, and hypotony in immediate postoperative period is inevitable. Fig. 2 compares the end result of the two techniques.
We believe that "scleral tuck technique" has several advantages over "scleral flap technique." It is less time-consuming as it avoids scleral dissection and it is cost-effective as it does not require glue. Fibrin glue besides increasing cost has other issues such as availability, quality, and its off-label use. By watertight closure, postoperative hypotony, and its sequelae-like vitreous hemorrhage, macular edema and choroidal detachment are avoided. By incorporating modification suggested by us, "scleral tuck technique" can be made more secure and the incidence of re-intervention can be reduced.
In the past 6 months, seven eyes of six patients have been operated with modified technique. All eyes had visual recovery from one line less than preoperative best-corrected vision with aphakic glasses to upto two lines better to their best-corrected preoperative visual acuity. No intraoperative complications were encountered except tearing of superficial scleral flap during step 2 in one eye. One eye had some vitreous hemorrhage during sclerotomy which delayed visual recovery till it absorbed spontaneously in 15 days. There has been no incidence of haptic breakage, late erosion, or endophthalmitis in any of these patients.
In the modified technique, parts of the haptic are lying over the sclera but these do not cause any foreign body sensation as these are under conjunctiva and tenon capsule, and second, the end of the haptic is securely buried into the sclera. In a prize-winning film at ASCRS Film Festival 2015, Yamene et al. demonstrated a technique (instagrid.me/y/AQiXqbp-A1k), where exteriorized haptic lies over the sclera and its tip is flanged like the end of a dumble to prevent its slippage into the sclera. In comparison to that, in our modification, only segments Letters to the Editor of haptic lie over the sclera and its end is securely buried into the sclera. We believe that this will prevent extrusion of the haptic tip out of the conjunctiva in late postoperative period.
Letters to the Editor
More cases and longer follow-ups are required to compare the results of this modification with the established techniques of scleral flap and scleral tuck. This is the reason this has been presented as correspondence so that others can also evaluate this modification.
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Sir, I read with interest the case report on the conjunctival leiomyosarcoma reported by Montes et al. [1] Leiomyosarcoma is one of the most common and serious smooth muscle tumors (SMTs) in the body. Patients infected with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) are susceptible to various types of tumors, including SMTs. There is a close association between Epstein-Barr virus (EBV) infection and SMTs evolution in patients infected with HIV/AIDS. [2] Moreover, SMTs in these patients typically arise in multiple and very unusual sites that are not often observed in SMTs among immunocompetent individuals. [3] To my knowledge, HIV infection is an important health problem in Spain. Although no recent data are yet present on the exact seroprevalence HIV infection in Spain, the available data pointed out that the overall HIV seroprevalence among persons seeking HIV testing was reported to be substantial (2.5%). [4] I presume that HIV infection should be critically considered in the studied patient with leiomyosarcoma affecting the unusual site. Hence, the diagnostic algorithm of immunohistochemical stains and in situ hybridization for EBV-encoded ribonucleic acid in the surgically resected tumor tissues as well as blood CD4 count and viral overload estimations for HIV infection was solicited. If that diagnostic algorithm was contemplated and it revealed underling EBV-HIV infection, the case in question could truly extend the spectrum of ophthalmic leiomyosarcoma associated with EBV-HIV infection rarely reported in the literature so far. [5] Financial support and sponsorship Nil.
